Patent · US Active

Perfusion system

US11253642B2 · kind B2 · utility

2Cited by
12References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2020
Grant dateFeb 22, 2022
Priority date
Expiry dateDec 18, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/6009
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A perfusion container for directly administering to patients a dose of an antineoplastic drug calculated according to a patient's parameter, wherein the first perfusion container comprises a solution of antineoplastic drug at a concentration and volume such that the amount of antineoplastic drug in the container is equal to the calculated dose for one patient but less than the calculated dose for a second patient, the calculated dose is provided to first patient within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container, further the first perfusion container is accompanied by a second top-up perfusion container comprising a solution of antineoplastic drug at a concentration and volume such that the calculated dose is provided within 5% variance by directly administering the full volume of the solution of antineoplastic drug from the first perfusion container and the second top-up container to the second patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.